Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,579
  • Shares Outstanding, K 75,019
  • Annual Sales, $ 500 K
  • Annual Income, $ -21,480 K
  • 60-Month Beta 2.04
  • Price/Sales 165.04
  • Price/Cash Flow N/A
  • Price/Book 2.60
Trade CLSN with:

Options Overview

Details
  • Implied Volatility 232.68%
  • Historical Volatility 106.06%
  • IV Percentile 22%
  • IV Rank 13.98%
  • IV High 865.77% on 10/20/20
  • IV Low 129.77% on 03/24/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 405
  • Volume Avg (30-Day) 1,565
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 23,020
  • Open Int (30-Day) 28,338

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +70.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9650 +11.92%
on 04/21/21
2.1600 -50.00%
on 03/22/21
-1.1600 (-51.79%)
since 03/19/21
3-Month
0.9650 +11.92%
on 04/21/21
3.4800 -68.97%
on 02/11/21
-0.6600 (-37.93%)
since 01/21/21
52-Week
0.4305 +150.87%
on 11/02/20
6.5000 -83.38%
on 06/17/20
-0.0700 (-6.09%)
since 04/21/20

Most Recent Stories

More News
CELSION CORPORATION ANNOUNCES CLOSING OF $15 MILLION REGISTERED DIRECT OFFERING

Celsion Corporation (NASDAQ: CLSN) ("Celsion" or the "Company"), today announced the closing of its previously announced registered direct offering of 11,538,462 shares of common stock at a purchase price...

CLSN : 1.0600 (+8.16%)
Poster on Celsion Corporation's Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women's Cancer

Company reports further strengthening of R0 resection results in patients treated with GEN-1

CLSN : 1.0600 (+8.16%)
CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING

Celsion Corporation (NASDAQ: CLSN) ("Celsion" or the "Company"), today announced it has entered into definitive agreements with institutional investors for the purchase and sale of 11,538,462 shares of...

CLSN : 1.0600 (+8.16%)
Celsion Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 19, 2021 / Celsion Corp. (NASDAQ:CLSN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 19, 2021 at 11:00 AM Eastern...

CLSN : 1.0600 (+8.16%)
Celsion Corporation Reports 2020 Financial Results and Provides Business Update

Entered 2021 with a Focus on Cancer Immunotherapy and Next-Generation Infectious Vaccines and a Strong Balance Sheet

CLSN : 1.0600 (+8.16%)
Celsion Corporation to Hold Year-End 2020 Financial Results and Business Update Conference Call on Friday, March 19, 2021

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at...

CLSN : 1.0600 (+8.16%)
Do Options Traders Know Something About Celsion (CLSN) Stock We Don't?

Investors need to pay close attention to Celsion (CLSN) stock based on the movements in the options market lately.

CLSN : 1.0600 (+8.16%)
Poster on Celsion Corporation's Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women's Cancer

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that a poster on the Company's Phase I/II OVATION...

CLSN : 1.0600 (+8.16%)
Celsion Corporation to Participate in the Virtual 33ʳ�? Annual Roth Conference

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management will be holding one-on-one meetings...

CLSN : 1.0600 (+8.16%)
Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores

Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement

CLSN : 1.0600 (+8.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the...

See More

Key Turning Points

3rd Resistance Point 1.1752
2nd Resistance Point 1.1326
1st Resistance Point 1.0567
Last Price 1.0600
1st Support Level 0.9382
2nd Support Level 0.8956
3rd Support Level 0.8197

See More

52-Week High 6.5000
Fibonacci 61.8% 4.1815
Fibonacci 50% 3.4653
Fibonacci 38.2% 2.7490
Last Price 1.0600
52-Week Low 0.4305

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar